{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260622025442/en/Arrowhead-Pharmaceuticals-Receives-Marketing-Authorization-in-the-European-Union-for-REDEMPLO%C2%AE-plozasiran-to-Reduce-Triglycerides-in-Adults-with-Familial-Chylomicronemia-Syndrome-FCS", "message": "News view counter 809654 successfully enlarged"}